Global Polymyxin B for Injection Market Growth 2026-2032
The global Polymyxin B for Injection market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032.
United States market for Polymyxin B for Injection is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Polymyxin B for Injection is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Polymyxin B for Injection is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Polymyxin B for Injection players cover Xellia, Fresenius Kabi, Shanghai Pharmaceuticals, Eugia, Gland Pharma, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LP Information, Inc. (LPI) ' newest research report, the ?Polymyxin B for Injection Industry Forecast? looks at past sales and reviews total world Polymyxin B for Injection sales in 2025, providing a comprehensive analysis by region and market sector of projected Polymyxin B for Injection sales for 2026 through 2032. With Polymyxin B for Injection sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Polymyxin B for Injection industry.
This Insight Report provides a comprehensive analysis of the global Polymyxin B for Injection landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Polymyxin B for Injection portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Polymyxin B for Injection market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Polymyxin B for Injection and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Polymyxin B for Injection.
This report presents a comprehensive overview, market shares, and growth opportunities of Polymyxin B for Injection market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
United States market for Polymyxin B for Injection is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Polymyxin B for Injection is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Polymyxin B for Injection is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Polymyxin B for Injection players cover Xellia, Fresenius Kabi, Shanghai Pharmaceuticals, Eugia, Gland Pharma, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LP Information, Inc. (LPI) ' newest research report, the ?Polymyxin B for Injection Industry Forecast? looks at past sales and reviews total world Polymyxin B for Injection sales in 2025, providing a comprehensive analysis by region and market sector of projected Polymyxin B for Injection sales for 2026 through 2032. With Polymyxin B for Injection sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Polymyxin B for Injection industry.
This Insight Report provides a comprehensive analysis of the global Polymyxin B for Injection landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Polymyxin B for Injection portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Polymyxin B for Injection market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Polymyxin B for Injection and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Polymyxin B for Injection.
This report presents a comprehensive overview, market shares, and growth opportunities of Polymyxin B for Injection market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- 50,000 Units
- Others
- Hospital
- Clinics
- Other
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Xellia
- Fresenius Kabi
- Shanghai Pharmaceuticals
- Eugia
- Gland Pharma
- Soigner Pharma
- Incepta Pharmaceuticals
- Taj Pharmaceuticals
- What is the 10-year outlook for the global Polymyxin B for Injection market?
- What factors are driving Polymyxin B for Injection market growth, globally and by region?
- Which technologies are poised for the fastest growth by market and region?
- How do Polymyxin B for Injection market opportunities vary by end market size?
- How does Polymyxin B for Injection break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Polymyxin B for Injection Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Polymyxin B for Injection by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Polymyxin B for Injection by Country/Region, 2021, 2025 & 2032
2.2 Polymyxin B for Injection Segment by Type
2.2.1 50,000 Units
2.2.2 Others
2.2.3 Polymyxin B for Injection Sales by Type
2.2.3.1 Global Polymyxin B for Injection Sales Market Share by Type (2021-2026)
2.2.3.2 Global Polymyxin B for Injection Revenue and Market Share by Type (2021-2026)
2.2.3.3 Global Polymyxin B for Injection Sale Price by Type (2021-2026)
2.3 Polymyxin B for Injection Segment by Application
2.3.1 Hospital
2.3.2 Clinics
2.3.3 Other
2.3.4 Polymyxin B for Injection Sales by Application
2.3.4.1 Global Polymyxin B for Injection Sale Market Share by Application (2021-2026)
2.3.4.2 Global Polymyxin B for Injection Revenue and Market Share by Application (2021-2026)
2.3.4.3 Global Polymyxin B for Injection Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Polymyxin B for Injection Breakdown Data by Company
3.1.1 Global Polymyxin B for Injection Annual Sales by Company (2021-2026)
3.1.2 Global Polymyxin B for Injection Sales Market Share by Company (2021-2026)
3.2 Global Polymyxin B for Injection Annual Revenue by Company (2021-2026)
3.2.1 Global Polymyxin B for Injection Revenue by Company (2021-2026)
3.2.2 Global Polymyxin B for Injection Revenue Market Share by Company (2021-2026)
3.3 Global Polymyxin B for Injection Sale Price by Company
3.4 Key Manufacturers Polymyxin B for Injection Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Polymyxin B for Injection Product Location Distribution
3.4.2 Players Polymyxin B for Injection Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR POLYMYXIN B FOR INJECTION BY GEOGRAPHIC REGION
4.1 World Historic Polymyxin B for Injection Market Size by Geographic Region (2021-2026)
4.1.1 Global Polymyxin B for Injection Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Polymyxin B for Injection Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Polymyxin B for Injection Market Size by Country/Region (2021-2026)
4.2.1 Global Polymyxin B for Injection Annual Sales by Country/Region (2021-2026)
4.2.2 Global Polymyxin B for Injection Annual Revenue by Country/Region (2021-2026)
4.3 Americas Polymyxin B for Injection Sales Growth
4.4 APAC Polymyxin B for Injection Sales Growth
4.5 Europe Polymyxin B for Injection Sales Growth
4.6 Middle East & Africa Polymyxin B for Injection Sales Growth
5 AMERICAS
5.1 Americas Polymyxin B for Injection Sales by Country
5.1.1 Americas Polymyxin B for Injection Sales by Country (2021-2026)
5.1.2 Americas Polymyxin B for Injection Revenue by Country (2021-2026)
5.2 Americas Polymyxin B for Injection Sales by Type (2021-2026)
5.3 Americas Polymyxin B for Injection Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Polymyxin B for Injection Sales by Region
6.1.1 APAC Polymyxin B for Injection Sales by Region (2021-2026)
6.1.2 APAC Polymyxin B for Injection Revenue by Region (2021-2026)
6.2 APAC Polymyxin B for Injection Sales by Type (2021-2026)
6.3 APAC Polymyxin B for Injection Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Polymyxin B for Injection by Country
7.1.1 Europe Polymyxin B for Injection Sales by Country (2021-2026)
7.1.2 Europe Polymyxin B for Injection Revenue by Country (2021-2026)
7.2 Europe Polymyxin B for Injection Sales by Type (2021-2026)
7.3 Europe Polymyxin B for Injection Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Polymyxin B for Injection by Country
8.1.1 Middle East & Africa Polymyxin B for Injection Sales by Country (2021-2026)
8.1.2 Middle East & Africa Polymyxin B for Injection Revenue by Country (2021-2026)
8.2 Middle East & Africa Polymyxin B for Injection Sales by Type (2021-2026)
8.3 Middle East & Africa Polymyxin B for Injection Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Polymyxin B for Injection
10.3 Manufacturing Process Analysis of Polymyxin B for Injection
10.4 Industry Chain Structure of Polymyxin B for Injection
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Polymyxin B for Injection Distributors
11.3 Polymyxin B for Injection Customer
12 WORLD FORECAST REVIEW FOR POLYMYXIN B FOR INJECTION BY GEOGRAPHIC REGION
12.1 Global Polymyxin B for Injection Market Size Forecast by Region
12.1.1 Global Polymyxin B for Injection Forecast by Region (2027-2032)
12.1.2 Global Polymyxin B for Injection Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Polymyxin B for Injection Forecast by Type (2027-2032)
12.7 Global Polymyxin B for Injection Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Xellia
13.1.1 Xellia Company Information
13.1.2 Xellia Polymyxin B for Injection Product Portfolios and Specifications
13.1.3 Xellia Polymyxin B for Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Xellia Main Business Overview
13.1.5 Xellia Latest Developments
13.2 Fresenius Kabi
13.2.1 Fresenius Kabi Company Information
13.2.2 Fresenius Kabi Polymyxin B for Injection Product Portfolios and Specifications
13.2.3 Fresenius Kabi Polymyxin B for Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Fresenius Kabi Main Business Overview
13.2.5 Fresenius Kabi Latest Developments
13.3 Shanghai Pharmaceuticals
13.3.1 Shanghai Pharmaceuticals Company Information
13.3.2 Shanghai Pharmaceuticals Polymyxin B for Injection Product Portfolios and Specifications
13.3.3 Shanghai Pharmaceuticals Polymyxin B for Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Shanghai Pharmaceuticals Main Business Overview
13.3.5 Shanghai Pharmaceuticals Latest Developments
13.4 Eugia
13.4.1 Eugia Company Information
13.4.2 Eugia Polymyxin B for Injection Product Portfolios and Specifications
13.4.3 Eugia Polymyxin B for Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Eugia Main Business Overview
13.4.5 Eugia Latest Developments
13.5 Gland Pharma
13.5.1 Gland Pharma Company Information
13.5.2 Gland Pharma Polymyxin B for Injection Product Portfolios and Specifications
13.5.3 Gland Pharma Polymyxin B for Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Gland Pharma Main Business Overview
13.5.5 Gland Pharma Latest Developments
13.6 Soigner Pharma
13.6.1 Soigner Pharma Company Information
13.6.2 Soigner Pharma Polymyxin B for Injection Product Portfolios and Specifications
13.6.3 Soigner Pharma Polymyxin B for Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Soigner Pharma Main Business Overview
13.6.5 Soigner Pharma Latest Developments
13.7 Incepta Pharmaceuticals
13.7.1 Incepta Pharmaceuticals Company Information
13.7.2 Incepta Pharmaceuticals Polymyxin B for Injection Product Portfolios and Specifications
13.7.3 Incepta Pharmaceuticals Polymyxin B for Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Incepta Pharmaceuticals Main Business Overview
13.7.5 Incepta Pharmaceuticals Latest Developments
13.8 Taj Pharmaceuticals
13.8.1 Taj Pharmaceuticals Company Information
13.8.2 Taj Pharmaceuticals Polymyxin B for Injection Product Portfolios and Specifications
13.8.3 Taj Pharmaceuticals Polymyxin B for Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Taj Pharmaceuticals Main Business Overview
13.8.5 Taj Pharmaceuticals Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Polymyxin B for Injection Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Polymyxin B for Injection by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Polymyxin B for Injection by Country/Region, 2021, 2025 & 2032
2.2 Polymyxin B for Injection Segment by Type
2.2.1 50,000 Units
2.2.2 Others
2.2.3 Polymyxin B for Injection Sales by Type
2.2.3.1 Global Polymyxin B for Injection Sales Market Share by Type (2021-2026)
2.2.3.2 Global Polymyxin B for Injection Revenue and Market Share by Type (2021-2026)
2.2.3.3 Global Polymyxin B for Injection Sale Price by Type (2021-2026)
2.3 Polymyxin B for Injection Segment by Application
2.3.1 Hospital
2.3.2 Clinics
2.3.3 Other
2.3.4 Polymyxin B for Injection Sales by Application
2.3.4.1 Global Polymyxin B for Injection Sale Market Share by Application (2021-2026)
2.3.4.2 Global Polymyxin B for Injection Revenue and Market Share by Application (2021-2026)
2.3.4.3 Global Polymyxin B for Injection Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Polymyxin B for Injection Breakdown Data by Company
3.1.1 Global Polymyxin B for Injection Annual Sales by Company (2021-2026)
3.1.2 Global Polymyxin B for Injection Sales Market Share by Company (2021-2026)
3.2 Global Polymyxin B for Injection Annual Revenue by Company (2021-2026)
3.2.1 Global Polymyxin B for Injection Revenue by Company (2021-2026)
3.2.2 Global Polymyxin B for Injection Revenue Market Share by Company (2021-2026)
3.3 Global Polymyxin B for Injection Sale Price by Company
3.4 Key Manufacturers Polymyxin B for Injection Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Polymyxin B for Injection Product Location Distribution
3.4.2 Players Polymyxin B for Injection Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR POLYMYXIN B FOR INJECTION BY GEOGRAPHIC REGION
4.1 World Historic Polymyxin B for Injection Market Size by Geographic Region (2021-2026)
4.1.1 Global Polymyxin B for Injection Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Polymyxin B for Injection Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Polymyxin B for Injection Market Size by Country/Region (2021-2026)
4.2.1 Global Polymyxin B for Injection Annual Sales by Country/Region (2021-2026)
4.2.2 Global Polymyxin B for Injection Annual Revenue by Country/Region (2021-2026)
4.3 Americas Polymyxin B for Injection Sales Growth
4.4 APAC Polymyxin B for Injection Sales Growth
4.5 Europe Polymyxin B for Injection Sales Growth
4.6 Middle East & Africa Polymyxin B for Injection Sales Growth
5 AMERICAS
5.1 Americas Polymyxin B for Injection Sales by Country
5.1.1 Americas Polymyxin B for Injection Sales by Country (2021-2026)
5.1.2 Americas Polymyxin B for Injection Revenue by Country (2021-2026)
5.2 Americas Polymyxin B for Injection Sales by Type (2021-2026)
5.3 Americas Polymyxin B for Injection Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Polymyxin B for Injection Sales by Region
6.1.1 APAC Polymyxin B for Injection Sales by Region (2021-2026)
6.1.2 APAC Polymyxin B for Injection Revenue by Region (2021-2026)
6.2 APAC Polymyxin B for Injection Sales by Type (2021-2026)
6.3 APAC Polymyxin B for Injection Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Polymyxin B for Injection by Country
7.1.1 Europe Polymyxin B for Injection Sales by Country (2021-2026)
7.1.2 Europe Polymyxin B for Injection Revenue by Country (2021-2026)
7.2 Europe Polymyxin B for Injection Sales by Type (2021-2026)
7.3 Europe Polymyxin B for Injection Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Polymyxin B for Injection by Country
8.1.1 Middle East & Africa Polymyxin B for Injection Sales by Country (2021-2026)
8.1.2 Middle East & Africa Polymyxin B for Injection Revenue by Country (2021-2026)
8.2 Middle East & Africa Polymyxin B for Injection Sales by Type (2021-2026)
8.3 Middle East & Africa Polymyxin B for Injection Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Polymyxin B for Injection
10.3 Manufacturing Process Analysis of Polymyxin B for Injection
10.4 Industry Chain Structure of Polymyxin B for Injection
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Polymyxin B for Injection Distributors
11.3 Polymyxin B for Injection Customer
12 WORLD FORECAST REVIEW FOR POLYMYXIN B FOR INJECTION BY GEOGRAPHIC REGION
12.1 Global Polymyxin B for Injection Market Size Forecast by Region
12.1.1 Global Polymyxin B for Injection Forecast by Region (2027-2032)
12.1.2 Global Polymyxin B for Injection Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Polymyxin B for Injection Forecast by Type (2027-2032)
12.7 Global Polymyxin B for Injection Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Xellia
13.1.1 Xellia Company Information
13.1.2 Xellia Polymyxin B for Injection Product Portfolios and Specifications
13.1.3 Xellia Polymyxin B for Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Xellia Main Business Overview
13.1.5 Xellia Latest Developments
13.2 Fresenius Kabi
13.2.1 Fresenius Kabi Company Information
13.2.2 Fresenius Kabi Polymyxin B for Injection Product Portfolios and Specifications
13.2.3 Fresenius Kabi Polymyxin B for Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Fresenius Kabi Main Business Overview
13.2.5 Fresenius Kabi Latest Developments
13.3 Shanghai Pharmaceuticals
13.3.1 Shanghai Pharmaceuticals Company Information
13.3.2 Shanghai Pharmaceuticals Polymyxin B for Injection Product Portfolios and Specifications
13.3.3 Shanghai Pharmaceuticals Polymyxin B for Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Shanghai Pharmaceuticals Main Business Overview
13.3.5 Shanghai Pharmaceuticals Latest Developments
13.4 Eugia
13.4.1 Eugia Company Information
13.4.2 Eugia Polymyxin B for Injection Product Portfolios and Specifications
13.4.3 Eugia Polymyxin B for Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Eugia Main Business Overview
13.4.5 Eugia Latest Developments
13.5 Gland Pharma
13.5.1 Gland Pharma Company Information
13.5.2 Gland Pharma Polymyxin B for Injection Product Portfolios and Specifications
13.5.3 Gland Pharma Polymyxin B for Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Gland Pharma Main Business Overview
13.5.5 Gland Pharma Latest Developments
13.6 Soigner Pharma
13.6.1 Soigner Pharma Company Information
13.6.2 Soigner Pharma Polymyxin B for Injection Product Portfolios and Specifications
13.6.3 Soigner Pharma Polymyxin B for Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Soigner Pharma Main Business Overview
13.6.5 Soigner Pharma Latest Developments
13.7 Incepta Pharmaceuticals
13.7.1 Incepta Pharmaceuticals Company Information
13.7.2 Incepta Pharmaceuticals Polymyxin B for Injection Product Portfolios and Specifications
13.7.3 Incepta Pharmaceuticals Polymyxin B for Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Incepta Pharmaceuticals Main Business Overview
13.7.5 Incepta Pharmaceuticals Latest Developments
13.8 Taj Pharmaceuticals
13.8.1 Taj Pharmaceuticals Company Information
13.8.2 Taj Pharmaceuticals Polymyxin B for Injection Product Portfolios and Specifications
13.8.3 Taj Pharmaceuticals Polymyxin B for Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Taj Pharmaceuticals Main Business Overview
13.8.5 Taj Pharmaceuticals Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Polymyxin B for Injection Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Polymyxin B for Injection Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of 50,000 Units
Table 4. Major Players of Others
Table 5. Global Polymyxin B for Injection Sales by Type (2021-2026) & (K Units)
Table 6. Global Polymyxin B for Injection Sales Market Share by Type (2021-2026)
Table 7. Global Polymyxin B for Injection Revenue by Type (2021-2026) & ($ million)
Table 8. Global Polymyxin B for Injection Revenue Market Share by Type (2021-2026)
Table 9. Global Polymyxin B for Injection Sale Price by Type (2021-2026) & (US$/Unit)
Table 10. Global Polymyxin B for Injection Sale by Application (2021-2026) & (K Units)
Table 11. Global Polymyxin B for Injection Sale Market Share by Application (2021-2026)
Table 12. Global Polymyxin B for Injection Revenue by Application (2021-2026) & ($ million)
Table 13. Global Polymyxin B for Injection Revenue Market Share by Application (2021-2026)
Table 14. Global Polymyxin B for Injection Sale Price by Application (2021-2026) & (US$/Unit)
Table 15. Global Polymyxin B for Injection Sales by Company (2021-2026) & (K Units)
Table 16. Global Polymyxin B for Injection Sales Market Share by Company (2021-2026)
Table 17. Global Polymyxin B for Injection Revenue by Company (2021-2026) & ($ millions)
Table 18. Global Polymyxin B for Injection Revenue Market Share by Company (2021-2026)
Table 19. Global Polymyxin B for Injection Sale Price by Company (2021-2026) & (US$/Unit)
Table 20. Key Manufacturers Polymyxin B for Injection Producing Area Distribution and Sales Area
Table 21. Players Polymyxin B for Injection Products Offered
Table 22. Polymyxin B for Injection Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Polymyxin B for Injection Sales by Geographic Region (2021-2026) & (K Units)
Table 26. Global Polymyxin B for Injection Sales Market Share Geographic Region (2021-2026)
Table 27. Global Polymyxin B for Injection Revenue by Geographic Region (2021-2026) & ($ millions)
Table 28. Global Polymyxin B for Injection Revenue Market Share by Geographic Region (2021-2026)
Table 29. Global Polymyxin B for Injection Sales by Country/Region (2021-2026) & (K Units)
Table 30. Global Polymyxin B for Injection Sales Market Share by Country/Region (2021-2026)
Table 31. Global Polymyxin B for Injection Revenue by Country/Region (2021-2026) & ($ millions)
Table 32. Global Polymyxin B for Injection Revenue Market Share by Country/Region (2021-2026)
Table 33. Americas Polymyxin B for Injection Sales by Country (2021-2026) & (K Units)
Table 34. Americas Polymyxin B for Injection Sales Market Share by Country (2021-2026)
Table 35. Americas Polymyxin B for Injection Revenue by Country (2021-2026) & ($ millions)
Table 36. Americas Polymyxin B for Injection Sales by Type (2021-2026) & (K Units)
Table 37. Americas Polymyxin B for Injection Sales by Application (2021-2026) & (K Units)
Table 38. APAC Polymyxin B for Injection Sales by Region (2021-2026) & (K Units)
Table 39. APAC Polymyxin B for Injection Sales Market Share by Region (2021-2026)
Table 40. APAC Polymyxin B for Injection Revenue by Region (2021-2026) & ($ millions)
Table 41. APAC Polymyxin B for Injection Sales by Type (2021-2026) & (K Units)
Table 42. APAC Polymyxin B for Injection Sales by Application (2021-2026) & (K Units)
Table 43. Europe Polymyxin B for Injection Sales by Country (2021-2026) & (K Units)
Table 44. Europe Polymyxin B for Injection Revenue by Country (2021-2026) & ($ millions)
Table 45. Europe Polymyxin B for Injection Sales by Type (2021-2026) & (K Units)
Table 46. Europe Polymyxin B for Injection Sales by Application (2021-2026) & (K Units)
Table 47. Middle East & Africa Polymyxin B for Injection Sales by Country (2021-2026) & (K Units)
Table 48. Middle East & Africa Polymyxin B for Injection Revenue Market Share by Country (2021-2026)
Table 49. Middle East & Africa Polymyxin B for Injection Sales by Type (2021-2026) & (K Units)
Table 50. Middle East & Africa Polymyxin B for Injection Sales by Application (2021-2026) & (K Units)
Table 51. Key Market Drivers & Growth Opportunities of Polymyxin B for Injection
Table 52. Key Market Challenges & Risks of Polymyxin B for Injection
Table 53. Key Industry Trends of Polymyxin B for Injection
Table 54. Polymyxin B for Injection Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Polymyxin B for Injection Distributors List
Table 57. Polymyxin B for Injection Customer List
Table 58. Global Polymyxin B for Injection Sales Forecast by Region (2027-2032) & (K Units)
Table 59. Global Polymyxin B for Injection Revenue Forecast by Region (2027-2032) & ($ millions)
Table 60. Americas Polymyxin B for Injection Sales Forecast by Country (2027-2032) & (K Units)
Table 61. Americas Polymyxin B for Injection Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 62. APAC Polymyxin B for Injection Sales Forecast by Region (2027-2032) & (K Units)
Table 63. APAC Polymyxin B for Injection Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 64. Europe Polymyxin B for Injection Sales Forecast by Country (2027-2032) & (K Units)
Table 65. Europe Polymyxin B for Injection Revenue Forecast by Country (2027-2032) & ($ millions)
Table 66. Middle East & Africa Polymyxin B for Injection Sales Forecast by Country (2027-2032) & (K Units)
Table 67. Middle East & Africa Polymyxin B for Injection Revenue Forecast by Country (2027-2032) & ($ millions)
Table 68. Global Polymyxin B for Injection Sales Forecast by Type (2027-2032) & (K Units)
Table 69. Global Polymyxin B for Injection Revenue Forecast by Type (2027-2032) & ($ millions)
Table 70. Global Polymyxin B for Injection Sales Forecast by Application (2027-2032) & (K Units)
Table 71. Global Polymyxin B for Injection Revenue Forecast by Application (2027-2032) & ($ millions)
Table 72. Xellia Basic Information, Polymyxin B for Injection Manufacturing Base, Sales Area and Its Competitors
Table 73. Xellia Polymyxin B for Injection Product Portfolios and Specifications
Table 74. Xellia Polymyxin B for Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 75. Xellia Main Business
Table 76. Xellia Latest Developments
Table 77. Fresenius Kabi Basic Information, Polymyxin B for Injection Manufacturing Base, Sales Area and Its Competitors
Table 78. Fresenius Kabi Polymyxin B for Injection Product Portfolios and Specifications
Table 79. Fresenius Kabi Polymyxin B for Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 80. Fresenius Kabi Main Business
Table 81. Fresenius Kabi Latest Developments
Table 82. Shanghai Pharmaceuticals Basic Information, Polymyxin B for Injection Manufacturing Base, Sales Area and Its Competitors
Table 83. Shanghai Pharmaceuticals Polymyxin B for Injection Product Portfolios and Specifications
Table 84. Shanghai Pharmaceuticals Polymyxin B for Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 85. Shanghai Pharmaceuticals Main Business
Table 86. Shanghai Pharmaceuticals Latest Developments
Table 87. Eugia Basic Information, Polymyxin B for Injection Manufacturing Base, Sales Area and Its Competitors
Table 88. Eugia Polymyxin B for Injection Product Portfolios and Specifications
Table 89. Eugia Polymyxin B for Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 90. Eugia Main Business
Table 91. Eugia Latest Developments
Table 92. Gland Pharma Basic Information, Polymyxin B for Injection Manufacturing Base, Sales Area and Its Competitors
Table 93. Gland Pharma Polymyxin B for Injection Product Portfolios and Specifications
Table 94. Gland Pharma Polymyxin B for Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 95. Gland Pharma Main Business
Table 96. Gland Pharma Latest Developments
Table 97. Soigner Pharma Basic Information, Polymyxin B for Injection Manufacturing Base, Sales Area and Its Competitors
Table 98. Soigner Pharma Polymyxin B for Injection Product Portfolios and Specifications
Table 99. Soigner Pharma Polymyxin B for Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 100. Soigner Pharma Main Business
Table 101. Soigner Pharma Latest Developments
Table 102. Incepta Pharmaceuticals Basic Information, Polymyxin B for Injection Manufacturing Base, Sales Area and Its Competitors
Table 103. Incepta Pharmaceuticals Polymyxin B for Injection Product Portfolios and Specifications
Table 104. Incepta Pharmaceuticals Polymyxin B for Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 105. Incepta Pharmaceuticals Main Business
Table 106. Incepta Pharmaceuticals Latest Developments
Table 107. Taj Pharmaceuticals Basic Information, Polymyxin B for Injection Manufacturing Base, Sales Area and Its Competitors
Table 108. Taj Pharmaceuticals Polymyxin B for Injection Product Portfolios and Specifications
Table 109. Taj Pharmaceuticals Polymyxin B for Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 110. Taj Pharmaceuticals Main Business
Table 111. Taj Pharmaceuticals Latest Developments
Table 1. Polymyxin B for Injection Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Polymyxin B for Injection Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of 50,000 Units
Table 4. Major Players of Others
Table 5. Global Polymyxin B for Injection Sales by Type (2021-2026) & (K Units)
Table 6. Global Polymyxin B for Injection Sales Market Share by Type (2021-2026)
Table 7. Global Polymyxin B for Injection Revenue by Type (2021-2026) & ($ million)
Table 8. Global Polymyxin B for Injection Revenue Market Share by Type (2021-2026)
Table 9. Global Polymyxin B for Injection Sale Price by Type (2021-2026) & (US$/Unit)
Table 10. Global Polymyxin B for Injection Sale by Application (2021-2026) & (K Units)
Table 11. Global Polymyxin B for Injection Sale Market Share by Application (2021-2026)
Table 12. Global Polymyxin B for Injection Revenue by Application (2021-2026) & ($ million)
Table 13. Global Polymyxin B for Injection Revenue Market Share by Application (2021-2026)
Table 14. Global Polymyxin B for Injection Sale Price by Application (2021-2026) & (US$/Unit)
Table 15. Global Polymyxin B for Injection Sales by Company (2021-2026) & (K Units)
Table 16. Global Polymyxin B for Injection Sales Market Share by Company (2021-2026)
Table 17. Global Polymyxin B for Injection Revenue by Company (2021-2026) & ($ millions)
Table 18. Global Polymyxin B for Injection Revenue Market Share by Company (2021-2026)
Table 19. Global Polymyxin B for Injection Sale Price by Company (2021-2026) & (US$/Unit)
Table 20. Key Manufacturers Polymyxin B for Injection Producing Area Distribution and Sales Area
Table 21. Players Polymyxin B for Injection Products Offered
Table 22. Polymyxin B for Injection Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Polymyxin B for Injection Sales by Geographic Region (2021-2026) & (K Units)
Table 26. Global Polymyxin B for Injection Sales Market Share Geographic Region (2021-2026)
Table 27. Global Polymyxin B for Injection Revenue by Geographic Region (2021-2026) & ($ millions)
Table 28. Global Polymyxin B for Injection Revenue Market Share by Geographic Region (2021-2026)
Table 29. Global Polymyxin B for Injection Sales by Country/Region (2021-2026) & (K Units)
Table 30. Global Polymyxin B for Injection Sales Market Share by Country/Region (2021-2026)
Table 31. Global Polymyxin B for Injection Revenue by Country/Region (2021-2026) & ($ millions)
Table 32. Global Polymyxin B for Injection Revenue Market Share by Country/Region (2021-2026)
Table 33. Americas Polymyxin B for Injection Sales by Country (2021-2026) & (K Units)
Table 34. Americas Polymyxin B for Injection Sales Market Share by Country (2021-2026)
Table 35. Americas Polymyxin B for Injection Revenue by Country (2021-2026) & ($ millions)
Table 36. Americas Polymyxin B for Injection Sales by Type (2021-2026) & (K Units)
Table 37. Americas Polymyxin B for Injection Sales by Application (2021-2026) & (K Units)
Table 38. APAC Polymyxin B for Injection Sales by Region (2021-2026) & (K Units)
Table 39. APAC Polymyxin B for Injection Sales Market Share by Region (2021-2026)
Table 40. APAC Polymyxin B for Injection Revenue by Region (2021-2026) & ($ millions)
Table 41. APAC Polymyxin B for Injection Sales by Type (2021-2026) & (K Units)
Table 42. APAC Polymyxin B for Injection Sales by Application (2021-2026) & (K Units)
Table 43. Europe Polymyxin B for Injection Sales by Country (2021-2026) & (K Units)
Table 44. Europe Polymyxin B for Injection Revenue by Country (2021-2026) & ($ millions)
Table 45. Europe Polymyxin B for Injection Sales by Type (2021-2026) & (K Units)
Table 46. Europe Polymyxin B for Injection Sales by Application (2021-2026) & (K Units)
Table 47. Middle East & Africa Polymyxin B for Injection Sales by Country (2021-2026) & (K Units)
Table 48. Middle East & Africa Polymyxin B for Injection Revenue Market Share by Country (2021-2026)
Table 49. Middle East & Africa Polymyxin B for Injection Sales by Type (2021-2026) & (K Units)
Table 50. Middle East & Africa Polymyxin B for Injection Sales by Application (2021-2026) & (K Units)
Table 51. Key Market Drivers & Growth Opportunities of Polymyxin B for Injection
Table 52. Key Market Challenges & Risks of Polymyxin B for Injection
Table 53. Key Industry Trends of Polymyxin B for Injection
Table 54. Polymyxin B for Injection Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Polymyxin B for Injection Distributors List
Table 57. Polymyxin B for Injection Customer List
Table 58. Global Polymyxin B for Injection Sales Forecast by Region (2027-2032) & (K Units)
Table 59. Global Polymyxin B for Injection Revenue Forecast by Region (2027-2032) & ($ millions)
Table 60. Americas Polymyxin B for Injection Sales Forecast by Country (2027-2032) & (K Units)
Table 61. Americas Polymyxin B for Injection Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 62. APAC Polymyxin B for Injection Sales Forecast by Region (2027-2032) & (K Units)
Table 63. APAC Polymyxin B for Injection Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 64. Europe Polymyxin B for Injection Sales Forecast by Country (2027-2032) & (K Units)
Table 65. Europe Polymyxin B for Injection Revenue Forecast by Country (2027-2032) & ($ millions)
Table 66. Middle East & Africa Polymyxin B for Injection Sales Forecast by Country (2027-2032) & (K Units)
Table 67. Middle East & Africa Polymyxin B for Injection Revenue Forecast by Country (2027-2032) & ($ millions)
Table 68. Global Polymyxin B for Injection Sales Forecast by Type (2027-2032) & (K Units)
Table 69. Global Polymyxin B for Injection Revenue Forecast by Type (2027-2032) & ($ millions)
Table 70. Global Polymyxin B for Injection Sales Forecast by Application (2027-2032) & (K Units)
Table 71. Global Polymyxin B for Injection Revenue Forecast by Application (2027-2032) & ($ millions)
Table 72. Xellia Basic Information, Polymyxin B for Injection Manufacturing Base, Sales Area and Its Competitors
Table 73. Xellia Polymyxin B for Injection Product Portfolios and Specifications
Table 74. Xellia Polymyxin B for Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 75. Xellia Main Business
Table 76. Xellia Latest Developments
Table 77. Fresenius Kabi Basic Information, Polymyxin B for Injection Manufacturing Base, Sales Area and Its Competitors
Table 78. Fresenius Kabi Polymyxin B for Injection Product Portfolios and Specifications
Table 79. Fresenius Kabi Polymyxin B for Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 80. Fresenius Kabi Main Business
Table 81. Fresenius Kabi Latest Developments
Table 82. Shanghai Pharmaceuticals Basic Information, Polymyxin B for Injection Manufacturing Base, Sales Area and Its Competitors
Table 83. Shanghai Pharmaceuticals Polymyxin B for Injection Product Portfolios and Specifications
Table 84. Shanghai Pharmaceuticals Polymyxin B for Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 85. Shanghai Pharmaceuticals Main Business
Table 86. Shanghai Pharmaceuticals Latest Developments
Table 87. Eugia Basic Information, Polymyxin B for Injection Manufacturing Base, Sales Area and Its Competitors
Table 88. Eugia Polymyxin B for Injection Product Portfolios and Specifications
Table 89. Eugia Polymyxin B for Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 90. Eugia Main Business
Table 91. Eugia Latest Developments
Table 92. Gland Pharma Basic Information, Polymyxin B for Injection Manufacturing Base, Sales Area and Its Competitors
Table 93. Gland Pharma Polymyxin B for Injection Product Portfolios and Specifications
Table 94. Gland Pharma Polymyxin B for Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 95. Gland Pharma Main Business
Table 96. Gland Pharma Latest Developments
Table 97. Soigner Pharma Basic Information, Polymyxin B for Injection Manufacturing Base, Sales Area and Its Competitors
Table 98. Soigner Pharma Polymyxin B for Injection Product Portfolios and Specifications
Table 99. Soigner Pharma Polymyxin B for Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 100. Soigner Pharma Main Business
Table 101. Soigner Pharma Latest Developments
Table 102. Incepta Pharmaceuticals Basic Information, Polymyxin B for Injection Manufacturing Base, Sales Area and Its Competitors
Table 103. Incepta Pharmaceuticals Polymyxin B for Injection Product Portfolios and Specifications
Table 104. Incepta Pharmaceuticals Polymyxin B for Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 105. Incepta Pharmaceuticals Main Business
Table 106. Incepta Pharmaceuticals Latest Developments
Table 107. Taj Pharmaceuticals Basic Information, Polymyxin B for Injection Manufacturing Base, Sales Area and Its Competitors
Table 108. Taj Pharmaceuticals Polymyxin B for Injection Product Portfolios and Specifications
Table 109. Taj Pharmaceuticals Polymyxin B for Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 110. Taj Pharmaceuticals Main Business
Table 111. Taj Pharmaceuticals Latest Developments
LIST OF FIGURES
Figure 1. Picture of Polymyxin B for Injection
Figure 2. Polymyxin B for Injection Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Polymyxin B for Injection Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Polymyxin B for Injection Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Polymyxin B for Injection Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Polymyxin B for Injection Sales Market Share by Country/Region (2025)
Figure 10. Polymyxin B for Injection Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of 50,000 Units
Figure 12. Product Picture of Others
Figure 13. Global Polymyxin B for Injection Sales Market Share by Type in 2026
Figure 14. Global Polymyxin B for Injection Revenue Market Share by Type (2021-2026)
Figure 15. Polymyxin B for Injection Consumed in Hospital
Figure 16. Global Polymyxin B for Injection Market: Hospital (2021-2026) & (K Units)
Figure 17. Polymyxin B for Injection Consumed in Clinics
Figure 18. Global Polymyxin B for Injection Market: Clinics (2021-2026) & (K Units)
Figure 19. Polymyxin B for Injection Consumed in Other
Figure 20. Global Polymyxin B for Injection Market: Other (2021-2026) & (K Units)
Figure 21. Global Polymyxin B for Injection Sale Market Share by Application (2025)
Figure 22. Global Polymyxin B for Injection Revenue Market Share by Application in 2026
Figure 23. Polymyxin B for Injection Sales by Company in 2026 (K Units)
Figure 24. Global Polymyxin B for Injection Sales Market Share by Company in 2026
Figure 25. Polymyxin B for Injection Revenue by Company in 2026 ($ millions)
Figure 26. Global Polymyxin B for Injection Revenue Market Share by Company in 2026
Figure 27. Global Polymyxin B for Injection Sales Market Share by Geographic Region (2021-2026)
Figure 28. Global Polymyxin B for Injection Revenue Market Share by Geographic Region in 2026
Figure 29. Americas Polymyxin B for Injection Sales 2021-2026 (K Units)
Figure 30. Americas Polymyxin B for Injection Revenue 2021-2026 ($ millions)
Figure 31. APAC Polymyxin B for Injection Sales 2021-2026 (K Units)
Figure 32. APAC Polymyxin B for Injection Revenue 2021-2026 ($ millions)
Figure 33. Europe Polymyxin B for Injection Sales 2021-2026 (K Units)
Figure 34. Europe Polymyxin B for Injection Revenue 2021-2026 ($ millions)
Figure 35. Middle East & Africa Polymyxin B for Injection Sales 2021-2026 (K Units)
Figure 36. Middle East & Africa Polymyxin B for Injection Revenue 2021-2026 ($ millions)
Figure 37. Americas Polymyxin B for Injection Sales Market Share by Country in 2026
Figure 38. Americas Polymyxin B for Injection Revenue Market Share by Country (2021-2026)
Figure 39. Americas Polymyxin B for Injection Sales Market Share by Type (2021-2026)
Figure 40. Americas Polymyxin B for Injection Sales Market Share by Application (2021-2026)
Figure 41. United States Polymyxin B for Injection Revenue Growth 2021-2026 ($ millions)
Figure 42. Canada Polymyxin B for Injection Revenue Growth 2021-2026 ($ millions)
Figure 43. Mexico Polymyxin B for Injection Revenue Growth 2021-2026 ($ millions)
Figure 44. Brazil Polymyxin B for Injection Revenue Growth 2021-2026 ($ millions)
Figure 45. APAC Polymyxin B for Injection Sales Market Share by Region in 2026
Figure 46. APAC Polymyxin B for Injection Revenue Market Share by Region (2021-2026)
Figure 47. APAC Polymyxin B for Injection Sales Market Share by Type (2021-2026)
Figure 48. APAC Polymyxin B for Injection Sales Market Share by Application (2021-2026)
Figure 49. China Polymyxin B for Injection Revenue Growth 2021-2026 ($ millions)
Figure 50. Japan Polymyxin B for Injection Revenue Growth 2021-2026 ($ millions)
Figure 51. South Korea Polymyxin B for Injection Revenue Growth 2021-2026 ($ millions)
Figure 52. Southeast Asia Polymyxin B for Injection Revenue Growth 2021-2026 ($ millions)
Figure 53. India Polymyxin B for Injection Revenue Growth 2021-2026 ($ millions)
Figure 54. Australia Polymyxin B for Injection Revenue Growth 2021-2026 ($ millions)
Figure 55. China Taiwan Polymyxin B for Injection Revenue Growth 2021-2026 ($ millions)
Figure 56. Europe Polymyxin B for Injection Sales Market Share by Country in 2026
Figure 57. Europe Polymyxin B for Injection Revenue Market Share by Country (2021-2026)
Figure 58. Europe Polymyxin B for Injection Sales Market Share by Type (2021-2026)
Figure 59. Europe Polymyxin B for Injection Sales Market Share by Application (2021-2026)
Figure 60. Germany Polymyxin B for Injection Revenue Growth 2021-2026 ($ millions)
Figure 61. France Polymyxin B for Injection Revenue Growth 2021-2026 ($ millions)
Figure 62. UK Polymyxin B for Injection Revenue Growth 2021-2026 ($ millions)
Figure 63. Italy Polymyxin B for Injection Revenue Growth 2021-2026 ($ millions)
Figure 64. Russia Polymyxin B for Injection Revenue Growth 2021-2026 ($ millions)
Figure 65. Middle East & Africa Polymyxin B for Injection Sales Market Share by Country (2021-2026)
Figure 66. Middle East & Africa Polymyxin B for Injection Sales Market Share by Type (2021-2026)
Figure 67. Middle East & Africa Polymyxin B for Injection Sales Market Share by Application (2021-2026)
Figure 68. Egypt Polymyxin B for Injection Revenue Growth 2021-2026 ($ millions)
Figure 69. South Africa Polymyxin B for Injection Revenue Growth 2021-2026 ($ millions)
Figure 70. Israel Polymyxin B for Injection Revenue Growth 2021-2026 ($ millions)
Figure 71. Turkey Polymyxin B for Injection Revenue Growth 2021-2026 ($ millions)
Figure 72. GCC Countries Polymyxin B for Injection Revenue Growth 2021-2026 ($ millions)
Figure 73. Manufacturing Cost Structure Analysis of Polymyxin B for Injection in 2026
Figure 74. Manufacturing Process Analysis of Polymyxin B for Injection
Figure 75. Industry Chain Structure of Polymyxin B for Injection
Figure 76. Channels of Distribution
Figure 77. Global Polymyxin B for Injection Sales Market Forecast by Region (2027-2032)
Figure 78. Global Polymyxin B for Injection Revenue Market Share Forecast by Region (2027-2032)
Figure 79. Global Polymyxin B for Injection Sales Market Share Forecast by Type (2027-2032)
Figure 80. Global Polymyxin B for Injection Revenue Market Share Forecast by Type (2027-2032)
Figure 81. Global Polymyxin B for Injection Sales Market Share Forecast by Application (2027-2032)
Figure 82. Global Polymyxin B for Injection Revenue Market Share Forecast by Application (2027-2032)
Figure 1. Picture of Polymyxin B for Injection
Figure 2. Polymyxin B for Injection Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Polymyxin B for Injection Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Polymyxin B for Injection Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Polymyxin B for Injection Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Polymyxin B for Injection Sales Market Share by Country/Region (2025)
Figure 10. Polymyxin B for Injection Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of 50,000 Units
Figure 12. Product Picture of Others
Figure 13. Global Polymyxin B for Injection Sales Market Share by Type in 2026
Figure 14. Global Polymyxin B for Injection Revenue Market Share by Type (2021-2026)
Figure 15. Polymyxin B for Injection Consumed in Hospital
Figure 16. Global Polymyxin B for Injection Market: Hospital (2021-2026) & (K Units)
Figure 17. Polymyxin B for Injection Consumed in Clinics
Figure 18. Global Polymyxin B for Injection Market: Clinics (2021-2026) & (K Units)
Figure 19. Polymyxin B for Injection Consumed in Other
Figure 20. Global Polymyxin B for Injection Market: Other (2021-2026) & (K Units)
Figure 21. Global Polymyxin B for Injection Sale Market Share by Application (2025)
Figure 22. Global Polymyxin B for Injection Revenue Market Share by Application in 2026
Figure 23. Polymyxin B for Injection Sales by Company in 2026 (K Units)
Figure 24. Global Polymyxin B for Injection Sales Market Share by Company in 2026
Figure 25. Polymyxin B for Injection Revenue by Company in 2026 ($ millions)
Figure 26. Global Polymyxin B for Injection Revenue Market Share by Company in 2026
Figure 27. Global Polymyxin B for Injection Sales Market Share by Geographic Region (2021-2026)
Figure 28. Global Polymyxin B for Injection Revenue Market Share by Geographic Region in 2026
Figure 29. Americas Polymyxin B for Injection Sales 2021-2026 (K Units)
Figure 30. Americas Polymyxin B for Injection Revenue 2021-2026 ($ millions)
Figure 31. APAC Polymyxin B for Injection Sales 2021-2026 (K Units)
Figure 32. APAC Polymyxin B for Injection Revenue 2021-2026 ($ millions)
Figure 33. Europe Polymyxin B for Injection Sales 2021-2026 (K Units)
Figure 34. Europe Polymyxin B for Injection Revenue 2021-2026 ($ millions)
Figure 35. Middle East & Africa Polymyxin B for Injection Sales 2021-2026 (K Units)
Figure 36. Middle East & Africa Polymyxin B for Injection Revenue 2021-2026 ($ millions)
Figure 37. Americas Polymyxin B for Injection Sales Market Share by Country in 2026
Figure 38. Americas Polymyxin B for Injection Revenue Market Share by Country (2021-2026)
Figure 39. Americas Polymyxin B for Injection Sales Market Share by Type (2021-2026)
Figure 40. Americas Polymyxin B for Injection Sales Market Share by Application (2021-2026)
Figure 41. United States Polymyxin B for Injection Revenue Growth 2021-2026 ($ millions)
Figure 42. Canada Polymyxin B for Injection Revenue Growth 2021-2026 ($ millions)
Figure 43. Mexico Polymyxin B for Injection Revenue Growth 2021-2026 ($ millions)
Figure 44. Brazil Polymyxin B for Injection Revenue Growth 2021-2026 ($ millions)
Figure 45. APAC Polymyxin B for Injection Sales Market Share by Region in 2026
Figure 46. APAC Polymyxin B for Injection Revenue Market Share by Region (2021-2026)
Figure 47. APAC Polymyxin B for Injection Sales Market Share by Type (2021-2026)
Figure 48. APAC Polymyxin B for Injection Sales Market Share by Application (2021-2026)
Figure 49. China Polymyxin B for Injection Revenue Growth 2021-2026 ($ millions)
Figure 50. Japan Polymyxin B for Injection Revenue Growth 2021-2026 ($ millions)
Figure 51. South Korea Polymyxin B for Injection Revenue Growth 2021-2026 ($ millions)
Figure 52. Southeast Asia Polymyxin B for Injection Revenue Growth 2021-2026 ($ millions)
Figure 53. India Polymyxin B for Injection Revenue Growth 2021-2026 ($ millions)
Figure 54. Australia Polymyxin B for Injection Revenue Growth 2021-2026 ($ millions)
Figure 55. China Taiwan Polymyxin B for Injection Revenue Growth 2021-2026 ($ millions)
Figure 56. Europe Polymyxin B for Injection Sales Market Share by Country in 2026
Figure 57. Europe Polymyxin B for Injection Revenue Market Share by Country (2021-2026)
Figure 58. Europe Polymyxin B for Injection Sales Market Share by Type (2021-2026)
Figure 59. Europe Polymyxin B for Injection Sales Market Share by Application (2021-2026)
Figure 60. Germany Polymyxin B for Injection Revenue Growth 2021-2026 ($ millions)
Figure 61. France Polymyxin B for Injection Revenue Growth 2021-2026 ($ millions)
Figure 62. UK Polymyxin B for Injection Revenue Growth 2021-2026 ($ millions)
Figure 63. Italy Polymyxin B for Injection Revenue Growth 2021-2026 ($ millions)
Figure 64. Russia Polymyxin B for Injection Revenue Growth 2021-2026 ($ millions)
Figure 65. Middle East & Africa Polymyxin B for Injection Sales Market Share by Country (2021-2026)
Figure 66. Middle East & Africa Polymyxin B for Injection Sales Market Share by Type (2021-2026)
Figure 67. Middle East & Africa Polymyxin B for Injection Sales Market Share by Application (2021-2026)
Figure 68. Egypt Polymyxin B for Injection Revenue Growth 2021-2026 ($ millions)
Figure 69. South Africa Polymyxin B for Injection Revenue Growth 2021-2026 ($ millions)
Figure 70. Israel Polymyxin B for Injection Revenue Growth 2021-2026 ($ millions)
Figure 71. Turkey Polymyxin B for Injection Revenue Growth 2021-2026 ($ millions)
Figure 72. GCC Countries Polymyxin B for Injection Revenue Growth 2021-2026 ($ millions)
Figure 73. Manufacturing Cost Structure Analysis of Polymyxin B for Injection in 2026
Figure 74. Manufacturing Process Analysis of Polymyxin B for Injection
Figure 75. Industry Chain Structure of Polymyxin B for Injection
Figure 76. Channels of Distribution
Figure 77. Global Polymyxin B for Injection Sales Market Forecast by Region (2027-2032)
Figure 78. Global Polymyxin B for Injection Revenue Market Share Forecast by Region (2027-2032)
Figure 79. Global Polymyxin B for Injection Sales Market Share Forecast by Type (2027-2032)
Figure 80. Global Polymyxin B for Injection Revenue Market Share Forecast by Type (2027-2032)
Figure 81. Global Polymyxin B for Injection Sales Market Share Forecast by Application (2027-2032)
Figure 82. Global Polymyxin B for Injection Revenue Market Share Forecast by Application (2027-2032)
